1.
Neurol Clin Neurosci
; 11(1): 49-51, 2023 Jan.
Article
in English
| MEDLINE | ID: covidwho-2272348
ABSTRACT
A 45-year-old man developed parkinsonism 3 weeks after being diagnosed with mild COVID-19. Levodopa and benserazide failed to improve his symptoms, necessitating ropinirole, and steroid treatment, which included a 5-day course of methylprednisolone followed by a 3-month oral prednisolone taper. One month after initiating steroid treatment, his symptoms improved significantly.